• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

XIAP缺陷中血清白细胞介素-18持续升高及其与噬血细胞性淋巴组织细胞增生症的关联。

Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.

作者信息

Wada Taizo, Kanegane Hirokazu, Ohta Kazuhide, Katoh Fumiyo, Imamura Toshihiko, Nakazawa Yozo, Miyashita Ritsuko, Hara Junichi, Hamamoto Kazuko, Yang Xi, Filipovich Alexandra H, Marsh Rebecca A, Yachie Akihiro

机构信息

Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.

出版信息

Cytokine. 2014 Jan;65(1):74-8. doi: 10.1016/j.cyto.2013.09.007. Epub 2013 Sep 29.

DOI:10.1016/j.cyto.2013.09.007
PMID:24084330
Abstract

X-linked lymphoproliferative syndrome (XLP) is a rare primary immunodeficiency characterized by increased vulnerability to Epstein-Barr virus infection. XLP type 1 is caused by mutations in SH2D1A, whereas X-linked inhibitor of apoptosis (XIAP) encoded by XIAP/BIRC4 is mutated in XLP type 2. In XIAP deficiency, hemophagocytic lymphohistiocytosis (HLH) occurs more frequently and recurrence is common. However, the underlying mechanisms remain mostly unknown. We describe the characteristics of the cytokine profiles of serum samples from 10 XIAP-deficient patients. The concentration of interleukin (IL)-18 was strikingly elevated in the patients presented with HLH, and remained high after the recovery from HLH although levels of other pro-inflammatory cytokines approached the normal range. Longitudinal examination of two patients demonstrated marked exacerbation of IL-18 levels during every occasion of HLH. These findings may suggest the association between HLH susceptibility and high serum IL-18 levels in XIAP deficiency.

摘要

X连锁淋巴增殖综合征(XLP)是一种罕见的原发性免疫缺陷病,其特征是对爱泼斯坦-巴尔病毒感染的易感性增加。1型XLP由SH2D1A基因突变引起,而X连锁凋亡抑制蛋白(XIAP)由XIAP/BIRC4编码,在2型XLP中发生突变。在XIAP缺乏症中,噬血细胞性淋巴组织细胞增生症(HLH)更频繁地发生且复发很常见。然而,其潜在机制大多仍不清楚。我们描述了10例XIAP缺乏症患者血清样本的细胞因子谱特征。在患有HLH的患者中,白细胞介素(IL)-18的浓度显著升高,并且在从HLH恢复后仍保持高水平,尽管其他促炎细胞因子的水平接近正常范围。对两名患者的纵向检查表明,在每次HLH发作期间IL-18水平都显著升高。这些发现可能提示在XIAP缺乏症中HLH易感性与高血清IL-18水平之间的关联。

相似文献

1
Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.XIAP缺陷中血清白细胞介素-18持续升高及其与噬血细胞性淋巴组织细胞增生症的关联。
Cytokine. 2014 Jan;65(1):74-8. doi: 10.1016/j.cyto.2013.09.007. Epub 2013 Sep 29.
2
X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.中国大陆 X 连锁淋巴组织增生症:临床、遗传和免疫学特征的综述。
Eur J Pediatr. 2020 Feb;179(2):327-338. doi: 10.1007/s00431-019-03512-7. Epub 2019 Nov 21.
3
SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症中的SAP和XIAP缺陷
Pediatr Int. 2012 Aug;54(4):447-54. doi: 10.1111/j.1442-200X.2012.03683.x.
4
Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.应用流式细胞术筛选 X 连锁淋巴组织增生性疾病患者,包括 SAP 缺陷和 XIAP 缺陷。
J Immunol Methods. 2010 Oct 31;362(1-2):1-9. doi: 10.1016/j.jim.2010.08.010. Epub 2010 Sep 9.
5
XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.XIAP 缺陷:一种独特的原发性免疫缺陷,最好归类为 X 连锁家族性噬血细胞性淋巴组织细胞增生症,而不是 X 连锁淋巴组织增生性疾病。
Blood. 2010 Aug 19;116(7):1079-82. doi: 10.1182/blood-2010-01-256099. Epub 2010 May 20.
6
Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With / Hypomorphic Gene Variants.伴有低表达基因变异的系统性爱泼斯坦-巴尔病毒阳性T/NK淋巴细胞增殖性疾病
Front Pediatr. 2019 May 21;7:183. doi: 10.3389/fped.2019.00183. eCollection 2019.
7
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).X 连锁淋巴组织增生症 1 型(XLP-1/SAP 缺乏症)与 2 型(XLP-2/XIAP 缺乏症)患者的临床异同。
Blood. 2011 Feb 3;117(5):1522-9. doi: 10.1182/blood-2010-07-298372. Epub 2010 Nov 30.
8
Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.一名患有新型X连锁凋亡抑制蛋白(XIAP)变异的男孩,其爱泼斯坦-巴尔病毒相关噬血细胞性淋巴组织细胞增生症并发冠状动脉扩张和急性肾损伤:病例报告
BMC Pediatr. 2020 Oct 2;20(1):456. doi: 10.1186/s12887-020-02359-4.
9
XIAP deficiency syndrome in humans.人类X连锁凋亡抑制蛋白缺乏综合征
Semin Cell Dev Biol. 2015 Mar;39:115-23. doi: 10.1016/j.semcdb.2015.01.015. Epub 2015 Feb 7.
10
Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.通过流式细胞术早期快速检测 X 连锁淋巴组织增生综合征伴 SH2D1A 突变。
Cytometry B Clin Cytom. 2011 Jan;80(1):8-13. doi: 10.1002/cyto.b.20552.

引用本文的文献

1
Insights into absence of lymphoma despite fulminant Epstein-Barr virus infection in patients with XIAP deficiency.X连锁凋亡抑制蛋白缺陷患者尽管感染暴发性爱泼斯坦-巴尔病毒却未发生淋巴瘤的相关见解。
JCI Insight. 2025 Jul 15;10(16). doi: 10.1172/jci.insight.193787. eCollection 2025 Aug 22.
2
NLRP3 inflammasome-driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors.NLRP3炎性小体驱动的噬血细胞性淋巴组织细胞增生症的发生独立于白细胞介素-1β和白细胞介素-18,且可被溴结构域和额外末端结构域(BET)抑制剂靶向作用。
Sci Adv. 2025 Jul 11;11(28):eadv0079. doi: 10.1126/sciadv.adv0079. Epub 2025 Jul 9.
3
Comprehensive flow cytometry-based diagnosis of XIAP deficiency.
基于流式细胞术的XIAP缺陷综合诊断
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf020.
4
Insights into the Absence of Lymphoma Despite Fulminant Epstein-Barr Virus Infection in Patients with XIAP Deficiency.XIAP 缺陷患者尽管感染暴发性 Epstein-Barr 病毒却未患淋巴瘤的原因探究
bioRxiv. 2025 Jan 18:2025.01.17.633616. doi: 10.1101/2025.01.17.633616.
5
IL-18 and IL-18BP: A Unique Dyad in Health and Disease.白细胞介素-18与白细胞介素-18结合蛋白:健康与疾病中的独特二元组
Int J Mol Sci. 2024 Dec 17;25(24):13505. doi: 10.3390/ijms252413505.
6
Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms.噬血细胞性淋巴组织细胞增生症:当前的治疗进展、新兴的靶向治疗和潜在机制。
J Hematol Oncol. 2024 Nov 7;17(1):106. doi: 10.1186/s13045-024-01621-x.
7
Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention.嵌合抗原受体 T 细胞疗法的全身毒性及潜在毒性监测指标。
Front Immunol. 2024 Aug 26;15:1422591. doi: 10.3389/fimmu.2024.1422591. eCollection 2024.
8
Anti-Interferon-γ Therapy for Cytokine Storm Syndromes.抗干扰素-γ治疗细胞因子风暴综合征。
Adv Exp Med Biol. 2024;1448:573-582. doi: 10.1007/978-3-031-59815-9_38.
9
Autoinflammatory Contributors to Cytokine Storm.自身炎症性疾病导致的细胞因子风暴
Adv Exp Med Biol. 2024;1448:385-397. doi: 10.1007/978-3-031-59815-9_26.
10
Inborn Errors of Immunity and Cytokine Storm Syndromes.先天性免疫缺陷和细胞因子风暴综合征。
Adv Exp Med Biol. 2024;1448:185-207. doi: 10.1007/978-3-031-59815-9_14.